GlycoMimetics
GLYC
#10327
Rank
NZ$17.53 M
Marketcap
NZ$0.27
Share price
-5.42%
Change (1 day)
-44.88%
Change (1 year)

GlycoMimetics (GLYC) - Total assets

Total assets on the balance sheet as of March 2025 : NZ$10.37 Million

According to GlycoMimetics 's latest financial reports the company's total assets are NZ$10.37 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

GlycoMimetics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$19.66 M-72.55%
2023-12-31NZ$71.65 M-12.19%
2022-12-31NZ$81.6 M-40.92%
2021-12-31NZ$0.13 B-30.22%
2020-12-31NZ$0.19 B-20.63%
2019-12-31NZ$0.24 B-22.13%
2018-12-31NZ$0.32 B76.9%
2017-12-31NZ$0.18 B195.87%
2016-12-31NZ$61.19 M-13.58%
2015-12-31NZ$70.8 M-3.12%
2014-12-31NZ$73.08 M1036.74%
2013-12-31NZ$6.42 M-71.29%
2012-12-31NZ$22.39 M-39.55%
2011-12-31NZ$37.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
bluebird bio
BLUE
NZ$0.51 B 4,839.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 3,483,290.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$263.67 B 2,541,946.47%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
NZ$333.76 B 3,217,693.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$6.45 M-37.78%๐Ÿ‡บ๐Ÿ‡ธ USA